基础医学与临床 ›› 2019, Vol. 39 ›› Issue (7): 937-942.

• 研究论文 • 上一篇    下一篇

高糖致心肌细胞肥大的长链非编码RNA表达谱分析

孟哲颖1,胡兵2,陈翠2,曹洪丽3,王静怡3,申锷3   

  1. 1. 上海交通大学附属第六人民医院门诊3楼
    2. 上海交通大学附属第六人民医院
    3. 上海交通大学附属同仁医院
  • 收稿日期:2018-04-18 修回日期:2018-10-07 出版日期:2019-07-05 发布日期:2019-07-02
  • 通讯作者: 申锷 E-mail:shene2008@163.com
  • 基金资助:
    国家自然科学基金;上海市长宁区科学技术委员会重点项目

lncRNA expression profile analysis in hypotrophic cardiomyocytes induced by high glucose

  • Received:2018-04-18 Revised:2018-10-07 Online:2019-07-05 Published:2019-07-02

摘要: 目的 探讨高糖诱导心肌细胞肥大中长链非编码RNA(lncRNAs)表达及其可能参与的生物学功能分析。 方法 原代培养心肌细胞,高糖处理48 h致心肌细胞肥大,分对照组(Con)和高糖组(HG),用高通量测序检测长链非编码RNA(lncRNAs)的表达情况。 结果 1)糖尿病致心肌细胞肥大中共筛选到14个差异表达lncRNAs,5个上调分别为ENSMUST00000195674, ENSMUST00000183707, ENSMUST00000195992, MSTRG.8385.2, MSTRG.9749.1,9个下调分别为ENSMUST00000195426, ENSMUST00000186944, ENSMUST00000182639, ENSMUST00000181094, ENSMUST00000125001, ENSMUST00000210380, MSTRG.8302.1, MSTRG.11564.1, MSTRG.13750.1。2)其中ENSMUST00000182639, ENSMUST00000181094, ENSMUST00000195674, MSTRG.8302.1可能通过调控Igf1来参与PI3K-Akt signaling pathway;AMPK signaling pathway;mTOR signaling pathway; Rap1 signaling pathway; HIF-1 signaling pathway; FoxO signaling pathway; Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy (DCM); Oxidative phosphorylation等信号通路。 结论 高糖致心肌细胞肥大中lncRNAs呈现显著差异性表达,并可能通过相应的信号通路参与高糖尿致心肌细胞肥大的病理生理过程。

关键词: 糖尿病心肌病, 心肌细胞肥大, 高通量测序, 长链非编码RNA

Abstract: Objective To explore the long-chain noncoding RNA (lncRNAs) expression and its possible biological functional analysis in hypotrophic cardiomyocytes induced by high glucose. Methods Neonatal mice cardiomyocytes were cultured by high glucose for processing 48 h and then randomly divided into the control group (Con) and the high sugar group (HG), the long-chain noncoding RNA (lncRNAs) expression were measured by using high throughput sequencing. Results 14 differentially expressed lncRNAs were screened, of which 5 were upregulated (ENSMUST00000195674, ENSMUST00000183707, ENSMUST00000195992, MSTRG.8385.2, MSTRG.9749.1) and 9 downregulated (ENSMUST00000195426, ENSMUST00000186944, ENSMUST00000182639, ENSMUST00000181094, ENSMUST00000125001, ENSMUST00000210380, MSTRG. 8302.1, MSTRG.11564.1, MSTRG.13750.1). ENSMUST00000182639, ENSMUST00000181094, ENSMUST00000195674, MSTRG.8302.1 may participate in PI3K-Akt signaling pathway, AMPK signaling pathway, mTOR signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Hypertrophic cardiomyopathy, cardiomyopathy, or Oxidative phosphorylation by regulating Igf1.Conclusions LncRNAs in hypertrophic cardiomyocytes induced by high glucose are differentially expressed and might participated in the pathophysiological processes of hyperglycemic cardiomyocyte hypertrophy through corresponding signaling pathways.

Key words: diabetic cardiomyopathy, cardiomyocytes hypotrophy, high-throughput sequencing , lncRNA